Michael Diaz, MD
Lucio Gordan, MD
Florida Cancer Specialists & Research Institute (FCS) recently appointed Michael Diaz, MD, to the position of President and Managing Physician, effective January 1, 2022. Dr. Diaz succeeds Lucio Gordan, MD, who has served in that position since 2018. Dr. Gordan will continue to practice as a medical oncologist at the FCS Gainesville Cancer Center and serve as Chief Medical Officer of Therapeutics and Analytics for the statewide practice.
In announcing the decision of the FCS Executive Board, Chief Executive Officer Nathan H. Walcker, MBA, said of Dr. Diaz: “Through his compassionate
Nathan H. Walcker, MBA
delivery of cancer care and his involvement in research, advocacy, and philanthropic initiatives, he works tirelessly to ensure that patients with cancer in the Tampa Bay region and across Florida and the United States have ready access to affordable, high-quality cancer care in their local communities,” said Mr. Walcker. “He is ideally suited to fill this executive leadership role and lead our practice forward.”
Distinguished Career
Dr. Diaz joined FCS in 2011 and provides care at two FCS locations in St. Petersburg, Florida. He has served as Assistant Managing Physician for the statewide practice since November 2018. He currently serves on the FCS Executive Board and, for the past 7 years, as Director of Patient Advocacy.
Dr. Gordan commented: “Dr. Diaz is an extraordinary individual, physician, and experienced leader in community oncology. He is well respected nationally, and we are very fortunate that he has agreed to take my place in this leadership position. FCS will be in the most capable hands with him, the Executive Board, other physician leaders, and our executive and senior management.”
